Pharvaris N.V. (NasdaqGS: PHVS)
Health Care · Pharmaceuticals · CH
$30.86
-0.77% today · +40.9% 1Y
Pharvaris N.V. (NasdaqGS: PHVS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.18B and employs 148 people.
Over the last twelve months the share price has gained 40.9%, trading between 20.65 and 43.25.
Tweenvest scores Pharvaris N.V. across four factors: quality 48/100, value 87/100. Its strongest factor is value.
PHVS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.18B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.62
- Dividend yield
- —
- Beta (5Y)
- -2.46
- 52-week high
- $43.25
- 52-week low
- $20.65
- Avg volume (3M)
- —
- Shares outstanding
- 70.20M
- Employees
- 148
- Next earnings
- —
About Pharvaris N.V.
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
- ISIN
- NL00150005Y4
- Founded
- 2015
- Listed since
- Feb 4, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.NYSE: PBH | $2.28B | $49.18 | +1.97% |
| Bausch Health Companies Inc.NYSE: BHC | $2.26B | $5.98 | -1.08% |
| ApicHope Pharmaceutical Group Co., Ltd.SZSE: 300723 | $2.24B | CN¥33.42 | +0.45% |
| Haw Par Corporation LimitedSGX: H02 | $2.21B | S$12.77 | +0.55% |
| BrightGene Bio-Medical Technology Co., Ltd.SHSE: 688166 | $2.18B | CN¥33.53 | -6.37% |
| Tonghua Golden-Horse Pharmaceutical Industry Co,LtdSZSE: 000766 | $2.16B | CN¥14.97 | -1.25% |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.15B | CN¥22.88 | +1.24% |
| Dermapharm Holding SEXTRA: DMP | $2.13B | €38.30 | -0.26% |
Figures last refreshed Oct 11, 2026.